Ethyl cyanoacetate is an organic compound that contains a carboxylate ester and a nitrile. It is a colourless[1] liquid with a pleasant odor. This material is useful as a starting material for synthesis due to its variety of functional groups and chemical reactivity.[2]
Production
Ethyl cyanoacetate may be prepared in various ways:
The vapor pressure follows the Antoine equation log10(P) = A−(B/(T+C)) (P in bar, T in K) with A = 7.46724, B = 3693.663 and C = 16.138 in the temperature range from 341 to 479 K[6] Two polymorphic forms occur.[7][full citation needed] Below −111 °C, the crystal form II is dominant.[7] Above this temperature, the crystal form I is formed which melts at −22 °C.[8] The heat capacity at 25 °C is 220.22 J K−1 mol−1.[7]
Chemical properties
With its three different reactive centers—nitrile, ester, acidic methylene site—ethyl cyanoacetate is a versatile synthetic building block for a variety of functional and pharmacologically active substances. It contains an acidic methylene group, flanked by both the nitrile and carbonyl, and so can be used in condensation reactions like the Knoevenagel condensation or the Michael addition. This reactivity is similar to that of esters of malonic acid. As an example of reactivity at the nitrile, diethyl malonate is obtained from cyanoacetic acid ethyl ester by reaction with ethanol in the presence of strong acids.[3] Heating in the presence of sodium ethoxide forms the dimeric 3-amino-2-cyano-2-pentendiaciddiethylester.[9]
Nucleophilic attack at the ester group, as part of acyl substitution: reaction with ammonia leads to cyanoacetamide, which can be converted by dehydration with PCl5 or POCl3 to malononitrile.[11]
Ethyl cyanoacetate is a building block for the synthesis of heterocycles which are used for example as drugs:
Allopurinol, used for the treatment of chronic gout, can be synthesized starting with a Knoevenagel condensation with triethyl orthoformate; the condensation product is cyclized with hydrazine to give a substituted pyrazole and subsequently with formamide to allopurinol, a substituted pyrazolo-pyrimidine.[12]
^EP application 1028105, Hanselmann, Paul & Hildebrand, Stefan, "Process for the preparation of cyanoacetic esters", published 2000-08-16, assigned to Lonza AG
^EP patent 1208081, Hanselmann, Paul & Hildebrand, Stefan, "Method for producing cyanoacetic acid esters", issued 2004-04-14, assigned to Lonza AG
^Stull, D.R. (1947). "Vapor Pressure of Pure Substances Organic Compounds". Ind. Eng. Chem. 39 (4): 517–540. doi:10.1021/ie50448a022.
^ abcKhodzhaeva, M.G.; Bugakov, Yu.V.; Ismailov, T.S.: Heat capacity and thermodynamic functions of ethyl cyanoacetate in Khim.-Farm. Zhur. 21 (1987) 760-762, DOI:10.1007/BF00872889.
^Dorokhov, V. A.; Baranin, S. V.; Dib, A.; Bogdanov, V. S. (1992). "'Codimers' of N-(pyrid-2-yl) amides and ethyl cyanoacetate". Russ. Chem. Bull. 41 (2): 287–291. doi:10.1007/bf00869516. S2CID95912295.
^Zheng, Shuyan; Yu, Chunhui; Shen, Zhengwu (2012). "Ethyl Cyanoacetate: A New Cyanating Agent for the Palladium-Catalyzed Cyanation of Aryl Halides". Org. Lett. 14 (14): 3644–3647. doi:10.1021/ol3014914. PMID22783893.
^Mary Eagleson: Concise encyclopedia chemistry, Walter de Gruyter, Berlin - New York 1994, ISBN3-11-011451-8.
^Axel Kleemann, Jürgen Engel: "Pharmazeutische Wirkstoffe", 2. Aufl., Georg Thieme, Stuttgart - New York 1982, ISBN3-13-558402-X.
^Beyer-Walter: "Lehrbuch der Organischen Chemie", 24. Aufl., S. Hirzel, Stuttgart - Leipzig 2004.
^Avetisyan, A. A.; Vanyan, É. V.; Dangyan, M. T. (1980). "Synthesis of functionally substituted coumarins". Chem. Heterocycl. Compounds. 15 (9): 959–960. doi:10.1007/BF00473834. S2CID102024617.
^Harald Strittmatter, Stefan Hildbrand and Peter Pollak "Malonic Acid and Derivatives" in Ullmann's Encyclopedia of Industrial Chemistry 2007, Wiley-VCH, Weinheim. doi:10.1002/14356007.a16_063.pub2